ReviveMed is a pioneer in the intersection of artificial intelligence and metabolomics. Metabolites are the closest link between cellular activity and what is observed in disease symptoms. ReviveMed uniquely overcomes the difficulties of identifying a large set of metabolites for each patient, based on technology developed at The Fraenkel Lab at MIT and published in Nature Methods. It further translates metabolomic data into novel therapeutic insights for drug and drug response biomarker discovery.

ReviveMed are proud supporters of the AI Applications in Biopharma Summit

Website: http://www.revive-med.com/